BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
79.37
-1.03 (-1.28%)
At close: Aug 26, 2026, 4:00 PM EDT
80.14
+0.77 (0.97%)
After-hours: Aug 26, 2026, 6:29 PM EDT
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $100 | Buy | Maintains | $100 | +25.99% | Aug 14, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $104 → $106 | Buy | Maintains | $104 → $106 | +33.55% | Aug 12, 2026 |
| Citi | Citi | Hold Maintains $93 → $94 | Hold | Maintains | $93 → $94 | +18.43% | Aug 12, 2026 |
| Barclays | Barclays | Buy Maintains $157 | Buy | Maintains | $157 | +97.81% | Aug 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $100 → $111 | Buy | Reiterates | $100 → $111 | +39.85% | Aug 11, 2026 |
| Jefferies | Jefferies | Buy Maintains $100 → $110 | Buy | Maintains | $100 → $110 | +38.59% | Aug 11, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $110 | Buy | Maintains | $110 | +38.59% | Aug 11, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $102 → $107 | Buy | Maintains | $102 → $107 | +34.81% | Aug 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.